[{"address1": "Surrey Research Park", "address2": "10 Nugent Road", "city": "Guildford", "zip": "GU2 7AF", "country": "United Kingdom", "phone": "44 14 8334 3434", "website": "https://angleplc.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated analysis. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with high analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal transition; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including enumeration of epithelial and mesenchymal CTC populations; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DNA damage response; Portrait PD-L1, evaluates CTCs; and custom CTC assays. ANGLE plc has a strategic partnership with Bio View Ltd to develop a human epidermal growth factor receptor 2 assay kit for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.", "fullTimeEmployees": 150, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew David William Newland ACA, Meng", "age": 62, "title": "Founder, CEO & Executive Director", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 372494, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian Francis Griffiths ACA, BA", "age": 59, "title": "CFO, Finance Director, Company Secretary & Executive Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 238608, "exercisedValue": 0, "unexercisedValue": 1090}, {"maxAge": 1, "name": "Mr. Martin  Cooke", "age": 54, "title": "Director of Operations & Regulatory Affairs", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Miller Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew John Holder", "age": 55, "title": "Head of Investor Relations", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anne-Sophie  Pailhes-Jimenez", "title": "Head of R&D and Senior Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brett  Swansiger", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nick  Claxton", "title": "Senior Vice President of Commercial Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.68, "open": 1.68, "dayLow": 1.68, "dayHigh": 1.68, "regularMarketPreviousClose": 1.68, "regularMarketOpen": 1.68, "regularMarketDayLow": 1.68, "regularMarketDayHigh": 1.68, "beta": 0.216, "volume": 1100, "regularMarketVolume": 1100, "averageVolume": 382, "averageVolume10days": 2242, "averageDailyVolume10Day": 2242, "bid": 1.3, "ask": 1.82, "bidSize": 40000, "marketCap": 54567748, "fiftyTwoWeekLow": 1.1295, "fiftyTwoWeekHigh": 4.0, "priceToSalesTrailing12Months": 24.962374, "fiftyDayAverage": 2.057, "twoHundredDayAverage": 2.051826, "currency": "USD", "enterpriseValue": 332152832, "floatShares": 196814292, "sharesOutstanding": 32252800, "impliedSharesOutstanding": 26058100, "bookValue": 0.088, "priceToBook": 15.000001, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -20132000, "trailingEps": -1.01, "enterpriseToRevenue": 151.945, "enterpriseToEbitda": -17.785, "52WeekChange": -0.18012422, "SandP52WeekChange": 0.24014747, "exchange": "OQX", "quoteType": "EQUITY", "symbol": "ANPCY", "underlyingSymbol": "ANPCY", "shortName": "ANGLE SPON ADR EACH REPR 10 ORD", "longName": "ANGLE plc", "firstTradeDateEpochUtc": 1430227800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8b6fda26-87fe-3f8d-87d2-bb083a39c8f6", "messageBoardId": "finmb_9804727", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.32, "recommendationKey": "none", "totalCash": 16218000, "totalCashPerShare": 0.062, "ebitda": -18676000, "totalDebt": 4554000, "quickRatio": 4.765, "currentRatio": 5.381, "totalRevenue": 2186000, "debtToEquity": 19.853, "revenuePerShare": 0.08, "returnOnAssets": -0.30567, "returnOnEquity": -0.63909, "freeCashflow": -8615625, "operatingCashflow": -14458000, "revenueGrowth": 0.592, "grossMargins": -0.18664, "operatingMargins": -9.27879, "financialCurrency": "GBP", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]